Evidence map›Paper›PMID 41142718›Full record

ArticleBioMed research international2025

Integrated Multiomics Validation of Key

Maryam Naeem, Nimra Munir, Ibrar Ahmed, Zarrin Basharat, Aneesa Sultan

Abstract read
In one paragraph

Article in BioMed research international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Integrated Multiomics Validation of KeyBioMed research international · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Maryam NaeemBiochemistry Department, Quaid-e-Azam University, Islamabad, Pakistan, qau.edu.pk.ORCID https://orcid.org/0009-0002-3393-7484
Nimra MunirBiochemistry Department, Quaid-e-Azam University, Islamabad, Pakistan, qau.edu.pk.ORCID https://orcid.org/0009-0000-2600-6054
Ibrar AhmedAlpha Genomics Private Limited, Islamabad, Pakistan.ORCID https://orcid.org/0000-0002-8744-9622
Zarrin BasharatAlpha Genomics Private Limited, Islamabad, Pakistan.ORCID https://orcid.org/0000-0003-1785-3803
Aneesa SultanBiochemistry Department, Quaid-e-Azam University, Islamabad, Pakistan, qau.edu.pk.ORCID https://orcid.org/0000-0002-7017-815X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Pancreatic ductal adenocarcinoma (PDAC) is the 3 Methods: With the aim of validating the signature biomarker ( Results: The in vitro validation of a signature biomarker in the Pakistani cohort reveals the pathogenic effect of mutations in the key Conclusion: In conclusion, our findings suggest

Indexed as

Biomarkers, TumorCarcinoma, Pancreatic DuctalGene Expression Regulation, NeoplasticMucinsPancreatic NeoplasmsCA-125 AntigenCohort StudiesFemaleGene Expression ProfilingHumansMaleMembrane ProteinsMiddle AgedMucin-4MultiomicsPakistanBiomarkers, TumorCA-125 AntigenMembrane ProteinsMUC16 protein, humanMUC4 protein, humanMucin-4Mucinsin vitro validationMAMsnoninvasive approachPDACRT-qPCRsignature biomarkertranscriptome analysisWES

Identifiers

PMID41142718
PMCPMC12547622

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.